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ABSTRACT
The Epstein–Barr virus protein (EB2) allows the
nuclear export of a particular subset of early and
late viral RNAs derived from intronless genes. EB2
is conserved among most herpesvirus members and
its presence is essential for the production of infec-
tious particles. Here we show that, besides its role
as a nuclear export factor, EB2 strongly stimulates
translation of unspliced mRNAs without affecting
overall cellular translation. Interestingly, this effect
can be reversed by the addition of an intron within
the gene. The spliced mRNA is then efficiently
exported and translated even in the absence of
EB2. Moreover, we show that EB2 associates with
translating ribosomes and increases the proportion
of its target RNA in the polyribosomal fraction.
Finally, testing of EB2 homolog proteins derived
from EBV-related herpesviruses, shows that, even
if they play similar roles within the replication cycle
of their respective virus, their mechanisms of action
are different.
INTRODUCTION
In eukaryotic cells, gene expression is tightly controlled
from the biogenesis of messenger RNAs (mRNAs)
within the cell nucleus, until their export and translation
in the cytoplasm (1). In particular, the control of mRNA
translation is a multi-step complex mechanism mediated
by a large number of factors. Translation initiation
appears to be the rate-limiting and most regulated step
of the overall translation mechanism (2,3). Regulation of
translation initiation is mediated mostly by initiation
factors, which recruit the 40S ribosomal subunit to the
50 cap of the mRNA, allow scanning to the initiation
codon and then the recruitment of the 60S ribosomal
subunit (4).
Even though maturation of pre-mRNAs occurs in a
diﬀerent cellular compartment than translation, proteins
that participate in the former process can also play a
role in the latter. Indeed, translation stimulation of
intron-containing genes has been observed in several sys-
tems and is linked to proteins that participate either in
splicing or in the export of spliced mRNAs (5–12).
Among these, the exon junction complex (EJC), which is
deposited during splicing and plays an important role in
mRNA surveillance, is able to modulate translation of
spliced mRNAs through the mTOR pathway (7). Other
proteins involved in translation stimulation of spliced
mRNAs comprise the Ser-Arg-rich (SR) proteins that
play a role not only in pre-mRNA splicing and spliceo-
some assembly but also in splice-site recognition and selec-
tion (13,14). Conversely, recent data have also shown
that some of the SR proteins, which shuttle from the
nucleus to the cytoplasm together with the spliced
mRNA, can be associated with translating ribosomes
to stimulate the translation of spliced mRNAs (11,15).
This would allow the cell to ensure that only fully spliced
RNAs are expressed as opposed to unspliced or incom-
pletely spliced RNAs that could result in translation of
aberrant proteins.
Viruses have evolved diﬀerent mechanisms to eﬃciently
export and translate unspliced RNAs. One example is the
constitutive transport element (CTE) present in simple
retroviruses, such as the Mason–Pﬁzner monkey virus
(MPMV), which interacts with the TAP/NXF1 export
protein and the cellular protein NXT1/p15 to promote
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(15–18). Again, translation stimulation of unspliced
RNAs containing the CTE seems to rely on SR proteins
such as 9G8 (15). For complex retroviruses, such as lenti-
viruses, the unspliced genomic RNA is exported by the
viral protein Rev which interacts with cis-acting sequences
located within the envelope coding region of the RNA,
allowing export and translation stimulation (19–22).
The Epstein–Barr virus (EBV) early protein EB2 (also
known as BMFL1, Mta or SM) shares several features
with mRNA export factors. It is able to interact with
RNA both in vitro and in vivo (23–25), it shuttles between
the nucleus and the cytoplasm and it allows the cytoplas-
mic accumulation of unspliced RNAs generated from
intronless and intron-containing genes, probably by the
recruitment of REF and TAP/NXF1 (24,26–28). EB2 is
essential for the production of viral particles and promotes
the nuclear export of some early and most late viral
mRNAs generated from EBV intronless genes (28).
Moreover, like EBV many other herpesviruses code for
a protein similar to EB2, i.e. ICP27 from herpes simplex
virus type 1 (HSV1) (29–31), UL69 from cytomegalovirus
(CMV) (32) ORF57 from Kaposi’s sarcoma-associated
herpesvirus (KSHV) (33) and ORF57 from herpesvirus
saimiri (HVS) (34). All these proteins act as nuclear
mRNA export factors but surprisingly their function
cannot be trans-complemented between each other
(27,35).
As cellular mRNA export factors, EB2 shuttles from
the nucleus to the cytoplasm, probably associated with
its target mRNAs, suggesting that it could also aﬀect
their translation. We thus tested the eﬀect of EB2 on
translation from an intronless reporter construct coding
for the Renilla luciferase. In this system, translation stim-
ulation was measured by analyzing the expression levels
of Renilla luciferase normalized to the amount of cyto-
plasmic mRNAs determined by quantitative PCR. Our
results show that EB2 strongly and speciﬁcally stimulates
translation of intronless mRNAs without aﬀecting overall
cellular translation or protein stability. Introduction of an
intron in this construct stimulates the eﬃciency of export
and translation of the luciferase mRNA and at the same
time abrogates the eﬀect of EB2. Interestingly, the increase
in translation of the luciferase mRNA generated from
the intronless construct in the presence of EB2, correlates
with an increase in the proportion of luciferase mRNA
associated with polyribosomes. Moreover, we show that
EB2 itself is associated with polyribosomes. Finally, a
comparison between EB2 homologs from EBV-related
viruses (HSV-1, CMV, KSHV) led us to conclude that
their mechanisms of action are diﬀerent.
MATERIALS AND METHODS
Cell lines and transfections
HeLa and HEK293T cells were grown in Dulbecco’s mod-
iﬁed Eagle medium supplemented with penicillin, strepto-
mycin and 5% fetal calf serum (Invitrogen). NIH3T3
PKR-deﬁcient cells (36) and NIH3T3 wild-type cells
were grown as described for HeLa cells. For experiments
using EBV gene-derived constructs, transfections were
performed in 100mm plates using calcium phosphate
with 15mg of total DNA (0.5mg of pTRE2-Flag.BDLF1,
0.25mg of pCI-Flag.EB2 and 0.5mg of pTet-On or pTet-
Oﬀ expression vectors (Clontech) and pUC18 up to 15mg).
When necessary, doxycyclin was added at a concentration
of 1mg/ml. For experiments using the luciferase reporter
plasmids, transfections were carried out in 60mm
plates using Lipofectamine 2000 (Invitrogen) following
the manufacturer’s protocol. For the metabolic labeling
experiments, transfection of HeLa cells with the EB2
expression plasmid was carried out in six-well plates
using Lipofectamine 2000 (Invitrogen). The eﬃciency of
transfection was evaluated by transfecting the pEGFP-C1
plasmid (Clontech) in the same conditions and counting
the number of green ﬂuorescent cells by FACS. Over 60%
of the cells expressed GFP. For polysomal fractionation,
HEK293T cells were seeded at 2 10
6 on a 150mm cul-
ture dish 3 days before polysomal fractionation. Forty-
eight hours before harvesting, cells were transfected with
1.25mg of luciferase-coding plasmid together or not with
6.25mg of pCI-Flag.EB2, using PEI reagent.
Plasmids
The pCI-Flag.EB2 construct has been previously
described (28). For pTRE2-Flag.BDLF1, the EBV
BDLF1 open reading frame tagged with the Flag epitope
was ampliﬁed by PCR and cloned into the BamHI and
XbaI sites of the pTRE2 expression plasmid (Clontech).
The pTet-On vector was supplied by Clontech (Tet-Oﬀ
and Tet-On gene expression systems). The pcDNA
GlobinRen reporter plasmid was constructed by cloning
the human b-globin 50UTR (with the authentic initiation
codon) followed by the Renilla luciferase reporter gene,
ampliﬁed by PCR from the p-Globin Renilla vector (37)
into the double digested (XbaI/AﬂII) pcDNA3.1 expres-
sion vector. For the pcDNAIntron-GlobinRen, the
sequence corresponding to the intron of the human
b-globin gene was ampliﬁed by PCR and cloned into the
pcDNAGlobinRen vector previously digested by XbaI.
pCI-mycORF57 contained the complete ORF57 coding
sequence (ﬁrst exon included) cloned in frame with the
myc epitope, in pCI (Promega). The expression plasmid
for UL69 (pCMV-UL69) was kindly provided by
T. Stamminger (38). The expression plasmid for ICP27
(pCI-FlagICP27) has been previously described (27).
RNA extraction and real-time quantitative PCR
(RT-PCR) from cytoplasmic RNAs
Cells were ﬁrst scraped from the dish and then resus-
pended in 200ml of cold RLNa buﬀer (10mM Tris–HCl
(pH 8), 10mM NaCl, 3mM MgCl2, 1mM DTT, 0.5%
NP40 and 10U/ml of RNaseOUT (Invitrogen). After
5min incubation on ice, lysed cells were centrifuged for
2min at 400g at 48C and the supernatant was then recov-
ered. One milliliter of Trizol (Invitrogen) was then
added to the supernatant and RNAs were extracted fol-
lowing the Trizol protocol provided by the manufacturer.
Cytoplasmic RNAs (1mg) were treated with RQ1 DNAse
(Promega) to avoid DNA contamination and reversed
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(Invitrogen) in a 20ml reaction mix at 428C for 1h.
PCRs were performed using a Taq core kit (Q-Biogen)
with a set of speciﬁc primer pairs (BDLF1 forward/
BDLF1 reverse: Table 1) on various amounts of the RT
reaction mixtures (0.05, 0.4, 1 or 2ml) to have a linearly
increasing signal after 25 PCR cycles. The PCR-ampliﬁed
fragments were then analyzed on 2% agarose gels. We
evaluated the endogenous expression of b-actin mRNA
by RT-PCR (b-actin forward/b-actin reverse: Table 1).
Ampliﬁcation of a 690-bp DNA fragment corresponding
to the b-actin mature mRNA showed that no DNA con-
tamination was present in our RNA preparations. We
tested for the presence of U6 snRNA using RT-PCR
(U6 forward/U6 reverse: Table 1).
For RT-qPCR, a 20ml reaction was prepared with 5ml
of template cDNA (1/20 diluted), 10ml of MESA green
SYBR premix (Eurogentec), 0.2mM of each primer and
subjected to ampliﬁcation using a ﬂuorescence thermocy-
cler (Applied Biosystems 7000 RT-PCR, Foster City, CA)
under the following conditions: 10min at 948C for initial
denaturation, followed by 40 cycles of denaturation at
958C for 15s, annealing at 608C for 15s and elongation
at 728C for 30s. This program was followed by a melting
curve analysis in order to verify the speciﬁcity of the PCR
product. Renilla luciferase was ampliﬁed in parallel with
the housekeeping gene GAPDH (for HeLa cells) or HPRT
(for mouse cells) and relative copy numbers of Renilla
cDNAs were compared to GAPDH using x
–Ct (where
x corresponds to the experimentally calculated ampliﬁca-
tion eﬃciency of each primer couple). The primer
sequences used in this study (presented in Table 1) were
designed using Beacon designer software (from
PREMIER Biosoft).
Western blotting analysis
Cells were collected by centrifugation, lysed on ice for
30min in 100ml of HNTG buﬀer (50mM HEPES pH
7.5; 150mM NaCl; 1% Triton X-100; 10% glycerol;
1mM EDTA; 1mM phenylmethylsulfonyl ﬂuoride).
Proteins were separated on 10% sodium dodecyl sulfate-
polyacrylamide electrophoresis gels and then transferred
to a nitrocellulose membrane by electroblotting (Hybond-
ECL; Amersham Biosciences). Membranes were
incubated with, respectively, anti-Flag M2 (Sigma) or
anti a-tubulin (T5168, Sigma) monoclonal antibodies or
an anti-PABP (kind gift from S. Morley) rabbit polyclonal
antibody (39). Goat anti-mouse horseradish peroxidase
conjugate or goat anti-rabbit horseradish peroxidase con-
jugate (Amersham) were used at a dilution of 1:5000 as
secondary antibodies. For immunoblot detection, the
ECL system (Amersham) was used.
Luciferase assays
Renilla activity from transfected cells was measured in a
Veritas
TM Luminometer (Turner Biosystems) using the
Renilla luciferase assay system (Promega Madison Co).
Luciferase activity was measured for identical amounts
of total protein as evaluated by Bradford assay.
Polyribosome fractionation
Polyribosome fractionation was performed essentially as
described previously (40,41). Forty-eight hours after trans-
fection, HEK293T cells were treated with 100mg/ml cyclo-
heximide at 378C for 5min and harvested by scraping
from the plate. In some experiments, EDTA was added
to the cell lysate at a ﬁnal concentration of 15mM to dis-
rupt the polysomes. The gradient was collected from
the top using a Piston Gradient Fractionator (BioComp,
New Brunswick, Canada) with concomitant measurement
of the absorbance at 254nm using an AKTA puriﬁer (GE
Healthcare, Amersham Biosciences, Piscataway, NJ)
coupled to a fraction collector. For western blotting,
20ml of each fraction were separated on 12% sodium
dodecyl sulfate-polyacrylamide electrophoresis gels and
then transferred to a PVDF membrane (Amersham bio-
sciences) by electroblotting. The membrane was then incu-
bated with various antibodies as described above in
the ‘western blotting analysis’ section. RNA extraction
was performed as described (15). RNAs were then reverse
transcribed and analyzed by quantitative PCR as
described above.
RESULTS
EB2 stimulates protein expression from EBV-derived
mRNAs
It has been shown that the EBV-encoded viral protein EB2
acts as a nuclear export factor for a particular subset of
mRNAs generated from intronless genes and for some
unspliced mRNAs derived from intron-containing genes
(24,26–28). However, although EB2 probably shuttles
from the nucleus to the cytoplasm together with the
exported RNA, the eﬀect of EB2 on mRNA translation
has never been reported. This prompted us to test whether
expression of EB2 could have an inﬂuence on translation
of its target viral mRNAs. We thus tested the eﬀect of EB2
on translation of an EBV-encoded mRNA whose cyto-
plasmic accumulation depends on EB2. In order to control
Table 1. PCR primers used in this study
a
Primer name Primer sequence
BDLF1 forward CAGATTTGAAAGTGGTAGTGTC
BDLF1 reverse TTATCTTAACCAGCAAGTGGCCG
b-actin forward (Human) GCTGCGTGTGGCTCCCGAGGAG
b-actin reverse (Human) ATCTTCATTGTGCTGGGTGCCAG
GAPDH forward (Human) TCCACCACCCTGTTGCTGTAG
GAPDH reverse (Human) ACCCACTCCTCCACCTTTGAC
HPRT forward (Mouse) TCATTATGCCGAGGATTTGGA
HPRT reverse (Mouse) CAGAGGGCCACAATGTGATG
Renilla forward AGGTGAAGTTCGTCGTCCAACATTATC
Renilla reverse GAAACTTCTTGGCACCTTCAACAATAGC
18S rRNA forward (Human) GTGGAGCGATTTGTCTGGTT
18S rRNA reverse (Human) CGCTGAGCCAGTCAGTGTAG
28S rRNA forward (Human) TGGGTTTTAAGCAGGAGGTG
28S rRNA reverse (Human) AACCTGTCTCACGACGGTCT
U6 forward (Human) CGCTTCGGCAGCACATATAC
U6 reverse (Human) AAAATATGGAACGCTTCACGA
aPrimers for real-time PCR were designed using Beacon designer
software (from PREMIER Biosoft).
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gene expression system (Clontech) to express the EBV
BDLF1 late mRNA (Figure 1A). For this, the
pTRE2-Flag-BDLF1 plasmid was transfected into HeLa
cells together with the pTet-On vector (Clontech) and with
or without the EB2 expression plasmid. Expression of EB2
and the BDLF1 protein was then monitored by western
blotting using an anti-Flag antibody (Figure 1B). The
amount of cytoplasmic BDLF1 mRNAs was quantiﬁed
by semi-quantitative RT-PCR (Figure 1C). In cells
cotransfected with the BDLF1 reporter plasmid and the
pTet-On vector, in the absence of doxycycline, no BDLF1
protein was detected (Figure 1B, lane 4) and only a low
amount of BDLF1 mRNAs were detected by RT-PCR
(Figure 1C, lane 4). In these conditions, the expression
of EB2 enhanced the cytoplasmic accumulation of the
corresponding BDLF1 mRNA (Figure 1C, lane 6) but
again no BDLF1 protein was detected (Figure 1B, lane
6). When doxycycline was added, the transcription of
BDLF1 mRNAs was strongly stimulated (Figure 1C,
lane 3) although only low levels of BDLF1 protein were
detected by western blot in the absence of EB2 (Figure 1B,
lane 3). However, in the presence of EB2 there was a large
increase in the amount of BDLF1 protein expressed
(Figure 1B, lane 5) although the amount of BDLF1
mRNA detected in the cytoplasm was comparable to
that in the absence of EB2 (Figure 1C, compare lanes 3
and 5). Indeed, in these conditions, transcription of
BDLF1 triggered by doxycycline was so strong that
it appeared to compensate for the otherwise poor cyto-
plasmic accumulation observed in the absence of EB2.
This allowed us to focus just on the eﬀect of EB2 on
BDLF1 translation without introducing a bias with the
amount of mRNA. Finally, upon addition of doxycycline,
only a weak signal corresponding to the BDLF1 mRNA
expression was detected by RT-PCR in the absence or
presence of EB2 (Figure 1C, lanes 1 and 2) and no
BDLF1 protein expression was detected (Figure 1B,
lanes 1 and 2) thus ruling out any non-speciﬁc eﬀect of
doxyxycline on BDLF1 expression in the absence of the
pTet-On vector. Essentially similar results were obtained
using the Tet-Oﬀ system for which transcription of
BDLF1 was triggered by the absence of doxycycline
(data not shown).
These results strongly suggest that EB2 is able to
stimulate protein expression from EBV-derived mRNAs.
EB2 stimulates both export and translation independently
of an EBV-specific sequence without affecting global
mRNA translation
In order to quantify the relative eﬀects of EB2 on mRNA
export and translation we designed a reporter construct
containing the 50UTR of the human b-Globin gene fol-
lowed by the Renilla luciferase coding region under the
control of the cytomegalovirus (CMV) immediate early
promoter (Figure 2A). It is important to note that this
construct does not contain any EBV-related sequence.
This construct was cotransfected together with the EB2
expression vector in HeLa cells and total luciferase activity
was analyzed 24h after transfection (Figure 2D, top
panel), while expression of EB2 was measured by western
blotting (Figure 2B). Cytoplasmic RNAs were extracted
and we ﬁrst quantiﬁed the amount of U6 snRNA in order
to make sure that our cytoplasmic fractions were not
contaminated by nuclear material (Figure 2C). Then cyto-
plasmic luciferase RNAs were quantiﬁed by relative quan-
titative RT-PCR using the housekeeping gene GAPDH as
an internal control (Supplementary Figure 1).
Interestingly, EB2 had no eﬀect on GAPDH mRNA
export thus ruling out any bias in the relative quantiﬁca-
tion of luciferase-coding mRNAs. As expected, expres-
sion of EB2 promoted the cytoplasmic accumulation of
luciferase-coding RNAs in a dose-dependent manner
(Figure 2D, middle panel) thus leading to a stimulation
of luciferase expression (Figure 2D, top panel). The luci-
ferase activity measured in each assay was then normal-
ized to the amount of luciferase cytoplasmic RNAs. This
gives an exact measure of the luciferase activity per RNA
molecule, and thus can be considered as a quantitative
representation of the translation rate. Interestingly, using
this quantiﬁcation we found that an average 7-fold stim-
ulation of luciferase mRNA translation in the presence of
EB2 was observed (Figure 2D, bottom panel).
Figure 1. EB2 stimulates expression of the late EBV viral protein
BDLF1. (A) Schematic representation of the BDLFI-encoding con-
struct pTRE2-Flag-BDLF1. (B) Western analysis of Flag-BDLF1
expression in HeLa cells transfected with pTRE2-Flag-BDLF1,
together with pTet-On and an expression plasmid for Flag-EB2 (pCI-
FEB2) as indicated in the ﬁgure. Doxycycline was added as indicated.
The M2 anti-Flag MAb was used to visualize both Flag-BDLF1 and
Flag-EB2 proteins. (C) Quantiﬁcation of the BDLF1 cytoplasmic RNA
by semi-quantitative RT-PCR in HeLa cells transfected as described
above.
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the neosynthesized luciferase protein we analyzed the sta-
bility of the luciferase protein in the absence and presence
of EB2. For this, we blocked cellular translation by adding
cycloheximide and measured luciferase decay activity over
time on cells expressing, or not, EB2. As shown in
Figure 3A, EB2 did not aﬀect the stability of the Renilla
luciferase protein, which had a 30-min half-life both in the
absence and presence of EB2.
Furthermore, the lack of EBV-derived sequences on the
luciferase reporter construct prompted us to test the eﬀect
of EB2 on global cellular mRNA translation. We thus
performed a metabolic labeling of cells expressing (or
not) EB2 (Figure 3B). For this, cells were pulsed in the
presence of radiolabeled methionine for 30min. Cells were
then lysed and proteins resolved on SDS–PAGE to quan-
tify the overall cellular translation rates. As shown in
Figure 3B, we did not detect any signiﬁcant diﬀerence in
translation rates between cells expressing EB2 and those
not expressing EB2.
Wealsowantedtoexcludethepossibilitythattranslation
stimulation driven by EB2 depends on protein kinase R
(PKR). PKR is the principal cellular factor involved in the
interferon-mediated inhibition of viral translation. This
kinase is activated by double-stranded RNA and this acti-
vation leads to the phosphorylation of initiation factor
eIF2a, thus inhibiting translation initiation of all cellular
and viral RNAs (42,43). We thus monitored luciferase
translation both in NIH3T3 PKR-deﬁcient cells (36)
and wt NIH3T3 in the presence or absence of EB2.
We found that EB2 was able to stimulate translation of
luciferasecodingmRNAsevenintheabsenceofPKR(Sup-
plementaryDataFigure2),whicharguesforamechanismof
translation stimulation independent of the PKR pathway.
Finally, to rule out the possibility that translation rates
were aﬀected by the amount of cytoplasmic mRNAs, thus
Figure 2. EB2 stimulates expression of a Renilla luciferase intronless gene at the translational level, independently of any viral-derived sequence. (A)
Schematic representation of the luciferase intronless coding vector used in this study (pcDNAGlobinRen) showing positions of the CMV promoter
and BGH polyadenylation signal. (B) Immunoblot of HeLa cells cotransfected with pcDNAGlobinRen together with the empty pCI vector or
increasing amounts of the FlagEB2-encoding plasmid, pCI-FlagEB2 (250 and 500ng). The M2 anti-Flag MAb was used to visualize Flag-EB2.
Asterisk denotes an unspeciﬁc band detected by the M2 anti-Flag antibody. (C) Quantiﬁcation of the amount of U6 snRNA present respectively in
the nuclear and cytoplasmic fractions of cellular extracts used in D. U6 snRNA was ampliﬁed by RT-PCR using the speciﬁc primer set indicated in
Table 1, and analyzed on a 2% agarose gel. (D) Measure of luciferase activity and quantiﬁcation of cytoplasmic luciferase-encoding mRNAs by
quantitative RT-PCR using GAPDH as an internal control. Total luciferase activity was measured 24h post-transfection (top panel) and the amount
of cytoplasmic luciferase coding mRNAs was quantiﬁed (middle panel). Translational eﬃciency (bottom panel) was calculated by normalizing the
total luciferase activity by reference to the amount of cytoplasmic luciferase mRNA. AU: arbitrary units.
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independent of EB2, we transfected increasing amounts
of luciferase expression vector in HeLa cells expressing,
or not, EB2 (Figure 3C). As EB2 expression leads to a
4–5-fold increase of mRNA levels in the cytoplasm, it
was of interest to test if increasing the amount of luciferase
mRNAs in the absence of EB2 could lead to a stimulation
of translation. For this, we measured luciferase translation
rates (luciferase activity/amount of luciferase mRNA) for
increasing amounts of cytoplasmic mRNAs either in the
presence or absence of EB2 (Figure 3C). As presented in
the top panel, luciferase expression increased proportion-
ally with the amount of cytoplasmic mRNAs, both in the
presence and absence of EB2. However, when luciferase
activity was normalized to the amount of cytoplasmic
mRNAs (which corresponds to the translation rate per
arbitrary unit of mRNA) there was no signiﬁcant change
in luciferase translation rates for increasing amounts
of cytoplasmic luciferase mRNAs in control (pCI) and
EB2-expressing cells (bottom panel). Nevertheless, transla-
tion rates in the presence of EB2 were systematically
4–5-fold more than those in the absence of EB2, and
this for identical mRNA amounts measured in the cyto-
plasm of the cells.
Taken together, these results show that EB2 stimulates
translation of mRNAs without aﬀecting the stability of
the neosynthesized protein. Interestingly, EB2 expression
does not aﬀect global mRNA translation. Moreover,
translation stimulation does not depend on the amount
of cytoplasmic mRNA available for translation.
Addition of an intron within the reporter construct
impairs translation stimulation driven by EB2
Our results show that EB2 is able to stimulate translation
of viral genes and that of a non-related reporter gene with-
out aﬀecting global cellular translation. Consequently,
we focused on understanding the lack of an eﬀect of
EB2 on cellular mRNA translation. Interestingly, EB2
has been shown to speciﬁcally stimulate the nuclear
export of mRNA generated from intronless genes (23).
This prompted us to test the translation of an mRNA
generated from an intron-containing gene in the presence
of EB2. We have thus introduced the b-globin intron
within the 50UTR of the luciferase reporter gene
(Figure 4A). In order to test the eﬃciency of splicing of
the corresponding mRNA, an RT-PCR from cytoplasmic
mRNAs was performed using a forward and reverse
primer ﬂanking the intron (Figure 4B). We observed
that transfection of the intronless construct in HeLa
cells led to the expression of an unspliced mRNA which,
upon RT-PCR, yielded a band of the same size to that
from the control PCR, performed directly using the DNA
plasmid as a template (Figure 4B, lanes 2, 3 and 4). On the
contrary, transfection of the intron-containing construct
led to the expression of an mRNA which, upon RT-PCR,
yielded a band slightly longer than that of the intronless
mRNA, but shorter than that of the control PCR
obtained from the intron-containing DNA plasmid
(Figure 4B, lanes 5–7). This band corresponds to the
spliced form of the luciferase-coding mRNA. Thus the
mRNA transcribed from this intron-containing reporter
gene was eﬃciently spliced both in the presence or absence
of EB2.
We then quantiﬁed the exact amount of cytoplasmic
luciferase mRNA by quantitative RT-PCR and measured
the corresponding luciferase activities (Supplementary
Figure 3). When translation rates were calculated by
normalizing the luciferase activity to the amount of
Figure 3. EB2 does not aﬀect protein stability or global cellular mRNA
translation and its eﬀect on translation is independent of the amount of
cytoplasmic luciferase coding mRNA. (A) Time-lapse measure of total
luciferase activity from HeLa cells mock transfected (pCI) or trans-
fected with an EB2 expression vector (pCI-FlagEB2) (250ng) after
addition of cycloheximide to block translation. Luciferase activity
was measured 0, 15, 30, 60, 120, 180 and 240min after addition of
cycloheximide to the cell medium. (B) Metabolic labeling of HeLa
cells mock transfected (pCI) or transfected with the EB2-encoding
plasmid (250ng), using
35S-labeled methionine. After a 30-min pulse
labeling, cells were lyzed and total cellular proteins resolved on 12%
SDS-PAGE. Total translation was quantiﬁed by phosphorimaging
using a Fujiﬁlm FLA5100. (C) Top panel: Luciferase activity was plot-
ted against the amount of cytoplasmic luciferase coding mRNAs in
HeLa cells transfected with increasing amounts of luciferase-encoding
plasmid in the absence (pCI) or presence (pCI-FlagEB2) of EB2 (250
and 500ng). Bottom panel: Translation rates per unit of luciferase-
encoding mRNAs (calculated by normalizing luciferase activity by ref-
erence to the amount of cytoplasmic luciferase-encoding mRNAs) in
HeLa cells transfected with increasing amounts of luciferase-encoding
plasmid in the absence or presence of EB2 expression plasmid. AU:
arbitrary units.
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10-fold more eﬃcient translation of the spliced mRNA
compared to unspliced in the absence of EB2. As expected,
in the presence of EB2 the translation rate of the unspliced
mRNA was increased by a factor 6. However, expression
of EB2 did not further stimulate translation of the spliced
luciferase mRNA but rather led to a mild inhibition.
It is noteworthy, that we also observed an inhibitory
eﬀect of EB2 on the accumulation of luciferase mRNA
generated from the intron-containing construct (Supple-
mentary Figure 3) which corroborates previously pub-
lished data from Ruvolo et al. (44).
These results indicate that EB2 speciﬁcally stimulates
translation of intronless mRNAs without signiﬁcantly
aﬀecting translation of spliced mRNAs.
EB2 co-sediments with polyribosomes and increases the
utilization of reporter mRNA by the translation machinery
To determine whether EB2 is associated with the transla-
tion machinery and to ﬁnd out whether it increases the
association of its target mRNAs with polyribosomes,
we performed sucrose gradient analysis to separate poly-
ribosomes from monoribosomes and uncomplexed riboso-
mal subunits. HEK293T cells were transfected with
pcDNAIntron-GlobinRen alone, pcDNAGlobinRen
alone or pcDNAGlobinRen together with pCI-
Flag.EB2. Cell extracts were prepared and fractionated
on 10–50% sucrose gradients and fractions were ﬁrst ana-
lyzed by western blotting. An example of the UV absor-
bance proﬁle of the gradients is shown in Figure 5A and
the corresponding 18S and 28S RNA proﬁle, determined
by RT-PCR, in Figure 5B. UV absorbance and the 18S/
28S RNA proﬁles from all gradients were very similar.
The polyribosome distribution of EB2 was compared
with that of PABP, a general translation factor for
polyA+ mRNA (45,46) (Figure 5A). As expected,
PABP was present across the gradient from mRNPs to
polyribosomal fractions. Interestingly, EB2 cosedimented
with the 80S ribosome but was also found in the lighter
polysomal fractions. As a control, a-tubulin was only
found associated with the uncomplexed ribosomal subunit
fractions. Furthermore, treatment of cytoplasmic extracts
with EDTA, which is known to induce a dissociation of
mono- and polyribosomes into ribosomal subunits,
induced a redistribution of EB2 to the top of the gradient
(Figure 5D and E).
We then analyzed the distribution of the reporter
mRNAs throughout our sucrose gradients by quantitative
RT-PCR (Figure 5C). Interestingly, the proportion of the
Renilla luciferase mRNA generated from the intron-less
construct, which is found associated with the polyriboso-
mal fractions, is greatly increased in the presence of EB2
(compare the middle and top panels). Furthermore, in the
latter case, the proﬁle of repartition of the Renilla lucifer-
ase mRNA throughout the gradient is very similar to that
obtained with the luciferase mRNA generated from the
intron-containing construct (bottom panel). As expected,
Renilla luciferase mRNA moved to the lighter fractions
of the gradient following EDTA treatment (Figure 5F).
Taken together, these data suggest that EB2 directly
increases the utilization of its target reporter mRNA by
the translation machinery.
EB2 viral homolog proteins exhibit different effects on
mRNA generated from intronless genes
Herpesviruses code for EB2 homolog proteins that also
serve as viral mRNA export factors. Interestingly, despite
Figure 4. Translation stimulation does not occur with spliced mRNAs.
(A) Schematic representation of the intronless (pcDNAGlobinRen)
and the intron-containing (pcDNAIntronGlobinRen) vectors encoding
the Renilla luciferase showing positions of the human b-globin intron
within the 50UTR of the luciferase construct (gray arrows correspond to
positions of the PCR primers used to test eﬃcient splicing of the intron).
(B) RT-PCR (using primers shown in A) from cells cotransfected with
pcDNAGlobinRen and pCI or the EB2-encoding plasmid pCI-FlagEB2
(lanes 2 and 3) or from cells cotransfected with pcDNAIntronGlobinRen
and pCI or pCI-FlagEB2 (lanes 5 and 6), or directly from the puriﬁed
DNA vector (lanes 4 and 7). (C) Luciferase activity normalized by
reference to the amount of cytoplasmic luciferase-encoding mRNAs
from HeLa cells cotransfected with pcDNAGlobinRen and pCI or pCI-
FlagEB2, or pcDNAIntronGlobinRen and pCI or pCI-FlagEB2.
The amount of luciferase-encoding mRNAs was monitored by quantita-
tive RT-PCR.
4938 Nucleic Acids Research, 2009, Vol. 37,No. 15Figure 5. EB2 cosediments with polyribosomes and enhances utilization of its target mRNA by the translation machinery. (A, B and C) Cell
cytosolic extracts of HEK293T transfected with pcDNAGlobinRen alone or pcDNAGlobinRen together with pCI-Flag.EB2 or pcDNAIntron-
GlobinRen alone, were fractionated across 10–50% sucrose gradients. (A) Fractions from the gradient corresponding to HEK293T transfected
with pcDNAGlobinRen together with pCI-Flag.EB2 were analyzed by western blotting with antibodies against the Flag epitope to detect Flag.EB2,
poly(A)-binding protein (PABP) or a-tubulin. (Top) UV absorbance (254nm) proﬁle of cytoplasmic ribonucleoprotein complexes. (B) 18S and 28S
RNA proﬁle determined by quantitative RT-PCR. (C) Quantiﬁcation of the Renilla luciferase reporter mRNA fractionated across 10–50% sucrose
gradients by quantitative RT-PCR. (Top panel) HEK293T transfected with pcDNAGlobinRen. (Middle panel) HEK293T transfected with
pcDNAGlobinRen together with pCI-Flag.EB2. (Bottom panel) HEK293T transfected with pcDNAIntron-GlobinRen. (D, E and F) An EDTA-
treated cytoplasmic extract of HEK 293T cells transfected with pcDNAGlobinRen together with pCIF.EB2 was fractionated across a 10–50%
sucrose gradients. (D) EB2 is relocalized to the top of the gradient. (Top) UV absorbance (254nm) proﬁle of cytoplasmic ribonucleoprotein
complexes. (E) 18S and 28S RNA proﬁle determined by quantitative RT-PCR. (F) Quantiﬁcation of the Renilla luciferase reporter mRNA
fractionated across a 10–50% sucrose gradient by quantitative RT-PCR.
Nucleic Acids Research, 2009,Vol.37, No. 15 4939their similarities, EB2 homolog proteins cannot trans-
complement each other for viral production (35,47).
Thus, it was of interest to test the eﬀect of EB2-related
proteins in our system. For this, we used proteins from
each herpesvirus sub-family: ICP27 from HSV1 (herpes
simplex virus 1), an a-herpesvirus, ORF57 from KSHV
(Kaposi’s sarcoma-associated herpesvirus), like EBV a
g-herpesvirus and UL69 from CMV (cytomegalovirus), a
b-herpesvirus. Among these proteins, only ICP27 has been
previously shown to stimulate translation of speciﬁc viral
mRNAs (48,49). In order to monitor the eﬀect of these
proteins in our luciferase reporter system, we cotrans-
fected HeLa cells with the intronless luciferase construct
and expression plasmids for the diﬀerent EB2-related her-
pesvirus proteins and we quantiﬁed both cytoplasmic
mRNA accumulation (Figure 6A) and luciferase activity
(not shown). Luciferase expression was again normalized
to the amount of cytoplasmic luciferase-encoding mRNAs
in order to speciﬁcally measure the impact of each viral
protein on translation (Figure 6B). Expression of each of
the viral proteins was veriﬁed by western blotting (data
not shown). Unexpectedly, the eﬀect observed with EB2
was not conserved for all of the homolog proteins. Indeed,
only UL69 led to a strong luciferase translation stimula-
tion similar to that of EB2 (i.e. 4–5-fold stimulation of
translation), whereas ICP27 and ORF57 did not have a
signiﬁcant eﬀect (Figure 6B). This was probably due to the
fact that neither ICP27 nor ORF57 appear to export the
luciferase mRNA (expression of ICP27 led in fact to a
40% reduction of the amount of luciferase cytoplasmic
mRNA) contrary to EB2 and UL69, which provoked a
4–5-fold increase of luciferase cytoplasmic mRNA levels
(Figure 6A).
This result shows that EB2 homologs derived from
related viruses have diﬀerential eﬀects on a heterologous
mRNA and suggests that export of the mRNA and stim-
ulation of its translation are strongly linked.
DISCUSSION
Although the role of EB2 in the nuclear export of
unspliced RNAs has been extensively studied, its eﬀect
on translation has never been evaluated. With the growing
evidence that cellular mRNA splicing and export factors
are also able to modulate translation of spliced mRNAs,
we decided to test whether the viral protein EB2 could also
aﬀect translation. Indeed, most of the EBV early and late
genes do not contain any intron, suggesting that both
export and translation of the corresponding mRNAs
should be very ineﬃcient. However, this defect is over-
come by expression of the early viral protein EB2, which
interacts with the viral mRNAs to facilitate their cytoplas-
mic accumulation. This tight interaction of EB2 with the
exported mRNA and its transit to the cytoplasm strongly
suggested that EB2 could also aﬀect translation. In fact,
expression of EB2 in cells coding for an EBV-derived
unspliced RNA (BDLF1) led to a strong stimulation of
BDLF1 accumulation that did not depend on an increase
in cytoplasmic levels of the corresponding mRNA. This
result indicates that, besides its role as a nuclear export
factor, EB2 can also stimulate translation of EBV
unspliced RNAs. Interestingly, the eﬀect of EB2 on pro-
tein accumulation from unspliced mRNAs did not depend
on any EBV-derived cis-acting sequence since expression
of an artiﬁcial unspliced mRNA encoding for the Renilla
luciferase was also strongly stimulated without aﬀecting
protein stability. Surprisingly, even though EB2 lacked a
requirement for a speciﬁc RNA sequence, its expression
did not aﬀect global cellular mRNA translation suggesting
a role for EB2 on translation of only a speciﬁc subset of
mRNAs.
Since EB2 has been shown to export mostly mRNAs
generated from intronless genes (23) including its speciﬁc
EBV-encoded target genes we tested the eﬀect of the intro-
duction of intronic sequences within the 50UTR of our
reporter gene. Interestingly, we found that after addition
of an intron within the luciferase reporter construct, EB2
was no longer able to stimulate translation, whereas it had
a strong eﬀect on the same RNA transcribed from an
intronless construct.
These results together with previous results showing
that EB2 can interact with mRNA independently of any
speciﬁc sequence (50) suggest that EB2 can bind to both
spliced and unspliced mRNAs. However, in the case of
unspliced mRNAs, which do not recruit the normal set
of splicing factors, EB2 would allow their export and stim-
ulate their translation to levels similar to those of spliced
mRNAs. In the case of intron-containing genes, EB2
Figure 6. Diﬀerential eﬀects on translation from EB2-related proteins
derived from diﬀerent herpesviruses. (A) Cytoplasmic luciferase mRNA
levels monitored by quantitative PCR in HeLa cells mock transfected
(pCI) or transfected with 500ng of EBV EB2, HSV-1 ICP27, HKSV
ORF57 and HCMV UL69-encoding plasmids. (B) Translation rate.
Luciferase activity was normalized by the amount of cytoplasmic
mRNAs from cells mock transfected (pCI) or transfected with EBV
EB2, HSV-1 ICP27, HKSV ORF57 and HCMV UL69-encoding
vectors, together with the reporter plasmid pcDNAGlobinRen. AU:
arbitrary units.
4940 Nucleic Acids Research, 2009, Vol. 37,No. 15could also bind to the mRNA but we suggest that either it
is excluded from the mRNA by a cellular splicing or
export factor, or it is exported to the cytoplasm with the
spliced mRNA. In the latter case, its eﬀect on translation
would be redundant in the presence of splicing proteins.
Indeed, it is possible that EB2 recruited cotranscription-
ally to nascent mRNAs is able to interact with an as yet
unknown cellular factor necessary for translation stimula-
tion of spliced mRNAs. This would explain the stimula-
tion of the translation of intronless mRNAs in the
presence of EB2. On the contrary, if EB2 also interacts
with spliced mRNAs, it could interfere with the cellular
factors that normally stimulate their export and transla-
tion. This would explain the mild inhibition of export and
translation that we observed upon addition of an intron in
our luciferase reporter construct.
In accordance with the fact that EB2 speciﬁcally stimu-
lates export and translation of mRNAs generated from
intronless genes we have shown that cellular mRNAs,
which are, in the majority, generated from intron-contain-
ing genes, are not globally aﬀected by expression of EB2.
There are however few cellular genes which are known for
their absence of introns. It would be interesting to look at
the eﬀect of EB2 on the export and translation of mRNAs
generated from such genes. In the case of EBV, most of
the viral mRNAs of the productive cycle are intronless.
We have previously shown that EB2 is necessary for the
eﬃcient export of the majority of these, but it is interesting
to note that some are eﬃciently exported even in the
absence of EB2, suggesting that they use an alternative
export pathway, independent of splicing. Such an alterna-
tive pathway has been previously reported with the SR
proteins, 9G8 and ASF/SF2, which have been found to
promote the recruitment of TAP to mRNPs (51). Another
interesting example of mRNA generated from an intron-
less gene and which is not aﬀected by EB2 is the ﬁreﬂy
luciferase mRNA expressed from an intronless construct
(25). However, although there is no eﬀect of EB2 on ﬁreﬂy
luciferase expression, EB2 bound eﬃciently to its mRNA
in vivo (25). Again, it is likely that this mRNA uses an
alternative pathway for its export, independent of splicing.
Thus, even if EB2 is associated with these mRNAs in vivo,
its eﬀect is probably redundant as discussed above in the
case of spliced mRNAs.
In order to deﬁnitively conclude on a direct eﬀect of
EB2 on translation eﬃciency we studied the association
of Renilla luciferase mRNAs with polyribosomes. The
data clearly showed that the proportion of Renilla lucifer-
ase mRNAs associated with polyribosomes is largely
increased in the presence of EB2. Moreover, we found
that there is also an association of EB2 with polyribo-
somes, suggesting that EB2 binds the mRNPs in the
nucleus, where it stimulates their export and then remains
associated with the mRNPs as far as the polyribosomes.
Taken together, these results argue for a role of EB2 in cis
similar to that of the EJC proteins responsible for the
translation stimulation of cellular mRNAs. One proposed
mechanism involves an interaction between the EJC and
the 48S preinitiation complex mediated by an interaction
between Y14:Magoh and the protein PYM (52). Another
mechanism involves the EJC-dependent recruitment of the
40S ribosomal protein S6 kinase 1 (S6K1) which is a cen-
tral player in the TOR signaling cascade (7). When acti-
vated by the TOR pathway, S6K1 enhances translation
initiation both by activating stimulatory factors and
by inactivating inhibitory factors bound at the 50 cap of
mRNAs. The SR protein ASF/SF2 has also recently been
reported to enhance translation initiation via recruitment
of mTOR (8).
Finally, we tested several EB2 homologous proteins
from other herpesviruses for their ability to stimulate
translation of the intronless luciferase gene. Among the
proteins tested, only UL69 from human cytomegalovirus
(hCMV) behaves like EB2, while ICP27 and ORF57 were
unable to stimulate luciferase translation. For UL69, this
is the ﬁrst report suggesting that this protein plays a role in
stimulation of translation. On the contrary, it has been
previously shown that ICP27 (from the herpes simplex
virus type 1) plays a role in regulating translation of a
subset of late viral mRNAs (48,49,53). However, the inter-
action between ICP27 and the viral mRNAs has been
shown to depend on speciﬁc RNA sequences distributed
along the viral genome (54). In addition, ICP27 has been
shown to be able to stimulate translation of a luciferase
mRNA only if it was previously tethered to it (53). Thus, it
is not surprising that in our system, ICP27 does not stim-
ulate Renilla luciferase mRNA translation nor cytoplas-
mic Renilla luciferase mRNA accumulation, suggesting
that translation stimulation is probably dependent on
the binding of the herpes simplex virus proteins to the
mRNA. Since all the herpesvirus EB2 homologous pro-
teins have been shown to shuttle from the nucleus to the
cytoplasm (31,38,55) it is tempting to speculate that they
ﬁrst interact with their unspliced mRNA targets inside the
nucleus, and then shuttle to the cytoplasm bound to these
mRNAs where they play a role in translation. Accordingly,
it is interesting to notice that ICP27 has also been shown
to be associated with polyribosomes (53). Taken together,
these results suggest ﬁrstly that both EB2 and the herpes-
virus EB2 homologous proteins have a direct role on trans-
lation of the mRNA they interact with, and secondly that
protein–mRNA interaction, mRNA export and transla-
tion stimulation are strongly linked.
EB2 expression is essential for viral particle production
and its absence leads to very poor viral DNA replication
probably because of the low expression of early viral
mRNAs that depend on EB2 for their export (i.e.
BALF5 and BALF2) (27). An even more drastic eﬀect
was seen on most of the late viral mRNAs (28,56). We
have shown here that EB2 expression leads to a 25-fold
stimulation of renilla luciferase reporter gene expression
with a cytoplasmic accumulation of the corresponding
mRNA stimulated 3.5-fold and the translation itself
stimulated from 5- to 7-fold. This suggests that the essen-
tial role of EB2 during the EBV productive cycle could
be explained by a combined role on mRNA export and
translation stimulation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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